PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities
- PMID: 7499194
- DOI: 10.1074/jbc.270.46.27407
PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities
Abstract
PTB domains are non-Src homology 2 (SH2) phosphotyrosine binding domains originally described in the receptor tyrosine kinase substrate, Shc. By serial truncation, we show that a 174-residue region of Shc p52 (33-206) has full PTB activity. We also show that a 173-residue region of insulin receptor substrate-1 (IRS-1; residues 144-316) has related PTB activity. In vitro both domains bind directly to activated insulin receptors. Binding is abrogated by substitution of Tyr-960 and selectively inhibited by phosphopeptides containing NPXY sequences. Phosphopeptide assays developed to compare PTB domain specificities show that the Shc PTB domain binds with highest affinity to psi XN beta 1 beta 2 pY motifs derived from middle T (mT), TrkA, ErbB4, or epidermal growth factor receptors (psi = hydrophobic, beta = beta-turn forming); the IRS-1 PTB domain does not bind with this motif. In contrast, both the Shc and IRS-1 PTB domains bind psi psi psi XXN beta 1 beta 2pY sequences derived from insulin and interleukin 4 receptors, although specificities vary in detail. Shc and IRS-1 are phosphorylated by distinct but overlapping sets of receptor-linked tyrosine kinases. These differences may be accounted for by the inherent specificities of their respective PTB domains.
Similar articles
-
Phosphotyrosine binding domains of Shc and insulin receptor substrate 1 recognize the NPXpY motif in a thermodynamically distinct manner.J Biol Chem. 1999 Mar 5;274(10):6114-21. doi: 10.1074/jbc.274.10.6114. J Biol Chem. 1999. PMID: 10037694
-
Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.Oncogene. 1999 May 20;18(20):3071-5. doi: 10.1038/sj.onc.1202879. Oncogene. 1999. PMID: 10340378
-
Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):963-8. doi: 10.1073/pnas.93.3.963. Proc Natl Acad Sci U S A. 1996. PMID: 8577769 Free PMC article.
-
The PI/PTB domain: a new protein interaction domain involved in growth factor receptor signaling.J Lab Clin Med. 1996 Sep;128(3):235-41. doi: 10.1016/s0022-2143(96)90022-0. J Lab Clin Med. 1996. PMID: 8783629 Review.
-
Insulin and IGF-I signaling through the insulin receptor substrate 1.Mol Reprod Dev. 1993 Aug;35(4):346-51; discussion 351-2. doi: 10.1002/mrd.1080350405. Mol Reprod Dev. 1993. PMID: 8398112 Review.
Cited by
-
The serine phosphorylations in the IRS-1 PIR domain abrogate IRS-1 and IR interaction.Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2401716121. doi: 10.1073/pnas.2401716121. Epub 2024 Apr 16. Proc Natl Acad Sci U S A. 2024. PMID: 38625937
-
Biochemical characterization of the Drosophila insulin receptor kinase and longevity-associated mutants.FASEB J. 2024 Jan;38(1):e23355. doi: 10.1096/fj.202301948R. FASEB J. 2024. PMID: 38071609 Free PMC article.
-
FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells.Elife. 2022 May 12;11:e76183. doi: 10.7554/eLife.76183. Elife. 2022. PMID: 35550247 Free PMC article.
-
Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice.J Biochem Mol Toxicol. 2021 Oct;35(10):e22876. doi: 10.1002/jbt.22876. Epub 2021 Aug 8. J Biochem Mol Toxicol. 2021. PMID: 34369032 Free PMC article.
-
Molecular Details of a Coupled Binding and Folding Reaction between the Amyloid Precursor Protein and a Folded Domain.ACS Chem Biol. 2021 Jul 16;16(7):1191-1200. doi: 10.1021/acschembio.1c00176. Epub 2021 Jun 23. ACS Chem Biol. 2021. PMID: 34161732 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
